Ignite Creation Date:
2024-05-05 @ 5:25 PM
Last Modification Date:
2024-10-26 @ 9:32 AM
Study NCT ID:
NCT00458211
Status:
COMPLETED
Last Update Posted:
2020-05-01
First Post:
2007-04-06
Brief Title:
Efficacy and Tolerability of Switching to Ziprasidone From Other Antipsychotics
Sponsor:
Bronx Psychiatric Center
Organization:
Bronx Psychiatric Center
Organization Data
Organization:
Bronx Psychiatric Center
Class:
OTHER_GOV
Study ID:
BPCIRB 03-02
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Bronx Psychiatric Center
Lead Sponsor Class:
OTHER_GOV
Responsible Party:
Nigel Bark MD
Responsible Party Title:
Director of Scizophrenia Research
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Bronx Psychiatric Center
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Rochester Psychiatric Center | OTHER |
| Pfizer | INDUSTRY |
| Buffalo Psychiatric Center | OTHER |